
The Decentralized Shift: NIH Funding and the Dismantling of the Clinical Trial Monopoly
The NIH’s redirection of 30% of its grant budget toward decentralized clinical trials (DCTs) using wearable biometrics is dismantling the geographic...
Read Full Story →

![[The Genomic Inflection Point: How August 2026 Medical Breakthroughs Are Rewriting Healthcare Economics]](https://www.crimaz.com/assets/images/no-image.png)
